ORANGE COUNTY, Calif. (November 12, 2023) – Beckman
Coulter, Inc. will exhibit a portfolio of laboratory solutions that
serve biotherapeutic formulation scientists at this year’s
Pharmaceutical Sciences World Congress, convening Nov. 14-18 at the
Morial Convention Center in New Orleans. Instruments in the
suite can be used for characterizing protein charge, analyzing
individual protein molecules, studying formation of dimers and
trimers and for quantifying large aggregates in applications from
basic biochemical discovery through large-scale production.
A capillary electrophoresis system, micro-ultracentrifuge and
particle size analyzers will be available for viewing in Booth 346,
along with systems experts who can answer questions and offer
advice regarding specific applications. Featured technologies
will include the PA 800 plus Pharmaceutical Analysis
System*, a next-generation CE platform that integrates
quantitative, qualitative and automated solutions for analysis of
protein purity, charge isoform distribution and glycan
heterogeneity.
The Optima MAX-XP Micro-Ultracentrifuge, which is ideal for
protein formulation applications, will be on display. This
centrifuge can produce sedimentation forces greater than 1,000,000
x g, features an intuitive, customizable user interface
and incorporates a number of enhanced biosafety attributes.
Quantifying aggregates between 1 and 10 microns is a hot topic
in protein formulation, and Beckman Coulter’s aggregate
counting solution, the Multisizer 4, will feature a new sample
holder that enables working with volumes as small as 4 mL.
The DelsaNano, Beckman Coulter’s dynamic light scattering and
zeta potential solution, will be shown, and can be used for sizing
proteins in solution and quickly studying their stability.
Completing the Particle Characterization offerings, the LS 13 320
laser diffraction system can size therapeutics ranging from 0.017
to 2000 microns in dry powders, aqueous suspensions or
solvents.
"Our full range of analytical products provides the formulation
scientist with the ability to fully characterize the activity and
components of their samples," said Matthew Rhyner, PhD, technical
marketing manager in the Beckman Coulter Particle Characterization
Business Center. "We look forward to talking with researchers
and development specialists at the conference and helping them
optimize their workflow."
Booth staff will be available to discuss the ProteomeLab XL-I
Protein Characterization System*, which, while not being exhibited,
will be of interest to protein chemists. This analytical centrifuge
provides large quantities of information about protein formulations
by sequentially collecting data from an on-board scanning UV/Vis
detection system and Rayleigh Interference Optics.
About Beckman Coulter
Beckman Coulter, Inc., based in Orange County, California,
develops, manufactures and markets products that simplify, automate
and innovate complex biomedical tests. This year marks the
company’s 75th anniversary of advancing healthcare. More than
200,000 Beckman Coulter systems operate in laboratories around the
world, supplying critical information for improving patient health
and reducing the cost of care. Recurring revenue, consisting of
consumable supplies (including reagent test kits), service and
operating-type lease payments,
represents about 80 percent of the company's 2009 revenue of $3.3
billion. For more information, visit www.beckmancoulter.com or
www.beckmancoulter.com/75years.
* For Laboratory Use Only; not for use in diagnostic
procedures.
Beckman Coulter and the stylized logo are registered trademarks
of Beckman Coulter, Inc.
Optima, DelsaNano, LS, Multisizer and ProteomeLab are trademarks of
Beckman Coulter, Inc.
SOURCE